KRAS.LUNG_UP.V1_DN
GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 8581 | 4.9 | 7.3 | 0.8 | 0.5 | 4.433 | 0.0162 | LY6D | lymphocyte antigen 6 complex, locus D |
2 | 6278 | 3.5 | 4.7 | 0.2 | 0.8 | 2.459 | 0.1163 | S100A7 | S100 calcium binding protein A7 |
3 | 3713 | 3.2 | 3.4 | 0.3 | 0.4 | 0.851 | 0.4466 | IVL | involucrin |
4 | 3851 | 3.8 | 4.5 | 0.6 | 0.1 | 1.982 | 0.1810 | KRT4 | keratin 4, type II |
5 | 43849 | 2.5 | 4.7 | 0.3 | 0.5 | 6.927 | 0.0048 | KLK12 | kallikrein-related peptidase 12 |
6 | 3868 | 3.3 | 6.0 | 0.7 | 0.6 | 5.243 | 0.0072 | KRT16 | keratin 16, type I |
7 | 1014 | 2.8 | 3.2 | 0.4 | 0.5 | 1.031 | 0.3608 | CDH16 | cadherin 16, KSP-cadherin |
8 | 51806 | 7.9 | 10.0 | 0.1 | 1.0 | 3.685 | 0.0656 | CALML5 | calmodulin-like 5 |
9 | 6707 | 2.9 | 3.4 | 0.5 | 0.9 | 0.711 | 0.5293 | SPRR3 | small proline-rich protein 3 |
10 | 3963 | 5.7 | 6.1 | 0.6 | 0.2 | 1.219 | 0.3325 | LGALS7 | lectin, galactoside-binding, soluble, 7 |
11 | 3860 | 4.9 | 3.7 | 0.3 | 0.2 | -5.729 | 0.0082 | KRT13 | keratin 13, type I |
12 | 9547 | 2.8 | 3.3 | 0.6 | 1.0 | 0.741 | 0.5092 | CXCL14 | chemokine (C-X-C motif) ligand 14 |
13 | 23242 | 5.6 | 6.6 | 0.1 | 0.1 | 11.625 | 0.0024 | COBL | cordon-bleu WH2 repeat protein |
14 | 5275 | 2.3 | 2.3 | 0.0 | 0.0 | 0.065 | 0.9510 | SERPINB13 | serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
15 | 6317 | 2.4 | 2.4 | 0.1 | 0.0 | -0.736 | 0.5138 | SERPINB3 | serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
16 | 57016 | 2.3 | 6.5 | 0.0 | 0.1 | 103.213 | 0.0000 | AKR1B10 | aldo-keto reductase family 1, member B10 (aldose reductase) |
17 | 5608 | 8.6 | 4.3 | 0.1 | 0.4 | -17.882 | 0.0010 | MAP2K6 | mitogen-activated protein kinase kinase 6 |
18 | 6283 | 2.5 | 2.3 | 0.3 | 0.0 | -0.982 | 0.4289 | S100A12 | S100 calcium binding protein A12 |
19 | 7051 | 7.4 | 7.5 | 0.2 | 0.2 | 0.464 | 0.6670 | TGM1 | transglutaminase 1 |
20 | 5650 | 2.3 | 2.3 | 0.0 | 0.0 | -0.113 | 0.9170 | KLK7 | kallikrein-related peptidase 7 |
21 | 55 | 4.0 | 4.8 | 0.4 | 0.2 | 3.307 | 0.0360 | ACPP | acid phosphatase, prostate |
22 | 10631 | 2.8 | 2.6 | 0.3 | 0.1 | -1.086 | 0.3593 | POSTN | periostin, osteoblast specific factor |
23 | 8424 | 3.0 | 3.8 | 0.7 | 1.8 | 0.781 | 0.4983 | BBOX1 | butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
24 | 1410 | 5.0 | 4.2 | 0.1 | 0.2 | -5.932 | 0.0058 | CRYAB | crystallin, alpha B |
25 | 11254 | 2.6 | 10.8 | 0.8 | 0.3 | 15.953 | 0.0013 | SLC6A14 | solute carrier family 6 (amino acid transporter), member 14 |
26 | 9935 | 8.0 | 10.3 | 0.5 | 0.1 | 8.079 | 0.0114 | MAFB | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
27 | 57124 | 2.7 | 3.0 | 0.7 | 0.7 | 0.400 | 0.7096 | CD248 | CD248 molecule, endosialin |
28 | 3635 | 5.6 | 3.3 | 1.1 | 0.9 | -2.829 | 0.0496 | INPP5D | inositol polyphosphate-5-phosphatase, 145kDa |
29 | 64108 | 3.9 | 4.6 | 0.7 | 0.7 | 1.333 | 0.2537 | RTP4 | receptor (chemosensory) transporter protein 4 |
30 | 1954 | 10.8 | 10.4 | 0.8 | 0.4 | -0.671 | 0.5503 | MEGF8 | multiple EGF-like-domains 8 |
31 | 5287 | 8.4 | 8.7 | 0.2 | 0.2 | 2.242 | 0.0884 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
32 | 23616 | 4.9 | 5.3 | 0.2 | 0.3 | 1.992 | 0.1333 | SH3BP1 | SH3-domain binding protein 1 |
33 | 3351 | 3.9 | 4.0 | 0.6 | 0.4 | 0.131 | 0.9025 | HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
34 | 3848 | 2.2 | 5.7 | 0.0 | 1.6 | 3.798 | 0.0628 | KRT1 | keratin 1, type II |
35 | 27113 | 12.3 | 11.5 | 0.8 | 0.2 | -1.769 | 0.2068 | BBC3 | BCL2 binding component 3 |
36 | 79755 | 6.8 | 7.2 | 0.5 | 0.7 | 0.778 | 0.4841 | ZNF750 | zinc finger protein 750 |
37 | 170679 | 7.0 | 7.0 | 0.3 | 0.7 | 0.038 | 0.9724 | PSORS1C1 | psoriasis susceptibility 1 candidate 1 |
38 | 1672 | 4.5 | 4.4 | 0.3 | 0.3 | -0.492 | 0.6484 | DEFB1 | defensin, beta 1 |
39 | 5625 | 6.7 | 6.9 | 0.1 | 0.2 | 1.339 | 0.2517 | PRODH | proline dehydrogenase (oxidase) 1 |
40 | 23498 | 3.4 | 4.3 | 0.4 | 0.5 | 2.328 | 0.0823 | HAAO | 3-hydroxyanthranilate 3,4-dioxygenase |
41 | 6261 | 5.8 | 5.9 | 0.4 | 0.1 | 0.448 | 0.6944 | RYR1 | ryanodine receptor 1 (skeletal) |
42 | 1280 | 3.5 | 3.4 | 0.5 | 0.4 | -0.297 | 0.7818 | COL2A1 | collagen, type II, alpha 1 |
43 | 129080 | 8.6 | 7.7 | 0.2 | 0.1 | -7.165 | 0.0042 | EMID1 | EMI domain containing 1 |
44 | 169611 | 4.6 | 5.2 | 0.2 | 0.1 | 4.875 | 0.0194 | OLFML2A | olfactomedin-like 2A |
45 | 51384 | 2.2 | 2.2 | 0.0 | 0.0 | 0.210 | 0.8494 | WNT16 | wingless-type MMTV integration site family, member 16 |
46 | 57399 | 2.4 | 2.5 | 0.3 | 0.5 | 0.258 | 0.8106 | LOC57399 | uncharacterized gastric protein ZA52P |
47 | 57523 | 5.5 | 5.2 | 0.2 | 0.2 | -1.553 | 0.1964 | NYNRIN | NYN domain and retroviral integrase containing |
48 | 22802 | 2.6 | 2.8 | 0.1 | 0.4 | 0.938 | 0.4326 | CLCA4 | chloride channel accessory 4 |
49 | 282808 | 7.2 | 6.8 | 0.2 | 0.1 | -4.053 | 0.0322 | RAB40AL | RAB40A, member RAS oncogene family-like |
50 | 51458 | 4.7 | 5.8 | 0.3 | 0.2 | 5.573 | 0.0052 | RHCG | Rh family, C glycoprotein |
51 | 10076 | 9.3 | 9.2 | 0.1 | 0.1 | -0.635 | 0.5609 | PTPRU | protein tyrosine phosphatase, receptor type, U |
52 | 79097 | 3.1 | 2.9 | 0.8 | 0.4 | -0.405 | 0.7140 | TRIM48 | tripartite motif containing 48 |
53 | 79696 | 6.0 | 6.1 | 0.4 | 0.3 | 0.526 | 0.6292 | ZC2HC1C | zinc finger, C2HC-type containing 1C |
54 | 8852 | 3.5 | 3.4 | 0.0 | 0.1 | -2.519 | 0.0920 | AKAP4 | A kinase (PRKA) anchor protein 4 |
55 | 11202 | 3.6 | 7.0 | 1.0 | 0.1 | 5.839 | 0.0265 | KLK8 | kallikrein-related peptidase 8 |
56 | 10249 | 2.5 | 2.6 | 0.2 | 0.2 | 0.787 | 0.4771 | GLYAT | glycine-N-acyltransferase |
57 | 4804 | 3.7 | 3.7 | 0.3 | 0.6 | -0.060 | 0.9558 | NGFR | nerve growth factor receptor |
58 | 200315 | 2.8 | 2.2 | 1.0 | 0.0 | -1.021 | 0.4146 | APOBEC3A | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A |
59 | 79644 | 7.1 | 7.5 | 0.0 | 0.3 | 2.502 | 0.1248 | SRD5A3 | steroid 5 alpha-reductase 3 |
60 | 2327 | 3.0 | 2.3 | 1.1 | 0.0 | -1.011 | 0.4180 | FMO2 | flavin containing monooxygenase 2 (non-functional) |
61 | 1028 | 6.7 | 6.4 | 0.3 | 0.2 | -1.560 | 0.1976 | CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
62 | 27076 | 6.9 | 8.1 | 0.3 | 0.2 | 5.629 | 0.0121 | LYPD3 | LY6/PLAUR domain containing 3 |
63 | 8608 | 5.7 | 5.3 | 0.9 | 0.2 | -0.725 | 0.5369 | RDH16 | retinol dehydrogenase 16 (all-trans) |
64 | 8578 | 5.4 | 6.5 | 0.6 | 2.9 | 0.614 | 0.5973 | SCARF1 | scavenger receptor class F, member 1 |
65 | 26290 | 2.8 | 2.8 | 0.2 | 0.3 | 0.167 | 0.8766 | GALNT8 | polypeptide N-acetylgalactosaminyltransferase 8 |
66 | 11012 | 2.3 | 11.1 | 0.0 | 0.5 | 31.539 | 0.0010 | KLK11 | kallikrein-related peptidase 11 |
67 | 222 | 9.7 | 9.3 | 0.3 | 0.2 | -2.186 | 0.1166 | ALDH3B2 | aldehyde dehydrogenase 3 family, member B2 |
68 | 8399 | 5.8 | 5.7 | 0.6 | 0.3 | -0.434 | 0.6951 | PLA2G10 | phospholipase A2, group X |
69 | 5158 | 7.0 | 5.7 | 0.1 | 0.8 | -2.922 | 0.0966 | PDE6B | phosphodiesterase 6B, cGMP-specific, rod, beta |
70 | 1382 | 8.8 | 8.4 | 0.2 | 0.8 | -0.943 | 0.4362 | CRABP2 | cellular retinoic acid binding protein 2 |
71 | 56603 | 2.9 | 2.7 | 0.8 | 0.4 | -0.442 | 0.6889 | CYP26B1 | cytochrome P450, family 26, subfamily B, polypeptide 1 |
72 | 6318 | 2.4 | 2.4 | 0.0 | 0.0 | 0.005 | 0.9962 | SERPINB4 | serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
73 | 3485 | 13.7 | 13.0 | 0.2 | 0.0 | -6.918 | 0.0164 | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa |
74 | 7441 | 2.3 | 2.3 | 0.0 | 0.0 | -0.556 | 0.6081 | VPREB1 | pre-B lymphocyte 1 |
75 | 729230 | 3.7 | 3.4 | 1.1 | 1.6 | -0.325 | 0.7630 | CCR2 | chemokine (C-C motif) receptor 2 |
76 | 3866 | 10.4 | 9.0 | 0.3 | 0.4 | -4.676 | 0.0140 | KRT15 | keratin 15, type I |
77 | 10451 | 8.9 | 12.3 | 0.1 | 0.1 | 37.542 | 0.0001 | VAV3 | vav 3 guanine nucleotide exchange factor |
78 | 55776 | 9.6 | 9.5 | 0.2 | 0.1 | -0.885 | 0.4492 | SAYSD1 | SAYSVFN motif domain containing 1 |
79 | 8495 | 7.5 | 7.4 | 0.6 | 0.7 | -0.194 | 0.8564 | PPFIBP2 | PTPRF interacting protein, binding protein 2 (liprin beta 2) |
80 | 9472 | 4.0 | 2.4 | 1.5 | 0.0 | -1.947 | 0.1908 | AKAP6 | A kinase (PRKA) anchor protein 6 |
81 | 810 | 8.4 | 8.9 | 0.2 | 0.0 | 4.559 | 0.0446 | CALML3 | calmodulin-like 3 |
82 | 6519 | 2.7 | 2.5 | 0.1 | 0.2 | -1.141 | 0.3344 | SLC3A1 | solute carrier family 3 (amino acid transporter heavy chain), member 1 |
83 | 3549 | 2.5 | 3.3 | 0.6 | 0.8 | 1.398 | 0.2447 | IHH | indian hedgehog |
84 | 1310 | 2.6 | 2.7 | 0.1 | 0.4 | 0.321 | 0.7770 | COL19A1 | collagen, type XIX, alpha 1 |
85 | 54587 | 2.4 | 2.3 | 0.3 | 0.0 | -1.010 | 0.4162 | MXRA8 | matrix-remodelling associated 8 |
86 | 1562 | 2.2 | 2.2 | 0.0 | 0.0 | 0.451 | 0.6926 | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 |
87 | 2619 | 3.2 | 3.9 | 1.0 | 1.2 | 0.801 | 0.4701 | GAS1 | growth arrest-specific 1 |
88 | 2560 | 3.1 | 3.0 | 0.2 | 0.1 | -0.916 | 0.4140 | GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 |
89 | 6457 | 7.4 | 7.1 | 0.3 | 0.3 | -0.953 | 0.3947 | SH3GL3 | SH3-domain GRB2-like 3 |
90 | 79703 | 7.1 | 7.5 | 0.4 | 0.1 | 1.550 | 0.2561 | C11orf80 | chromosome 11 open reading frame 80 |
91 | 8743 | 5.1 | 2.9 | 0.3 | 0.2 | -10.389 | 0.0024 | TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 |
92 | 23493 | 6.9 | 7.3 | 0.7 | 0.5 | 0.745 | 0.5004 | HEY2 | hes-related family bHLH transcription factor with YRPW motif 2 |
93 | 29953 | 2.9 | 2.8 | 0.2 | 0.3 | -0.271 | 0.8022 | TRHDE | thyrotropin-releasing hormone degrading enzyme |
94 | 3352 | 2.8 | 3.1 | 0.5 | 0.4 | 0.813 | 0.4657 | HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
95 | 1580 | 6.7 | 6.6 | 0.3 | 0.5 | -0.268 | 0.8046 | CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 |
96 | 6444 | 3.1 | 2.9 | 0.5 | 0.2 | -0.746 | 0.5181 | SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
97 | 6536 | 8.0 | 7.8 | 1.4 | 0.3 | -0.190 | 0.8656 | SLC6A9 | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
98 | 11063 | 3.8 | 4.2 | 0.5 | 0.5 | 0.830 | 0.4537 | SOX30 | SRY (sex determining region Y)-box 30 |
99 | 25840 | 12.7 | 12.0 | 0.1 | 0.4 | -2.710 | 0.0993 | METTL7A | methyltransferase like 7A |
100 | 933 | 3.0 | 3.5 | 0.4 | 1.8 | 0.460 | 0.6871 | CD22 | CD22 molecule |
101 | 80761 | 8.0 | 5.5 | 0.1 | 0.1 | -34.302 | 0.0000 | UPK3B | uroplakin 3B |
102 | 867 | 8.4 | 8.5 | 0.4 | 0.5 | 0.376 | 0.7268 | CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase |
103 | 643641 | 9.8 | 10.2 | 0.1 | 0.1 | 8.661 | 0.0011 | ZNF862 | zinc finger protein 862 |
104 | 55610 | 6.3 | 6.8 | 0.2 | 0.1 | 4.951 | 0.0222 | CCDC132 | coiled-coil domain containing 132 |
105 | 81628 | 9.6 | 10.0 | 0.4 | 0.2 | 1.263 | 0.3045 | TSC22D4 | TSC22 domain family, member 4 |
106 | 79132 | 5.9 | 11.0 | 0.3 | 0.3 | 19.290 | 0.0001 | DHX58 | DEXH (Asp-Glu-X-His) box polypeptide 58 |
107 | 6336 | 2.2 | 2.2 | 0.0 | 0.0 | -0.646 | 0.5543 | SCN10A | sodium channel, voltage gated, type X alpha subunit |
108 | 119 | 2.6 | 2.8 | 0.0 | 0.1 | 3.532 | 0.0505 | ADD2 | adducin 2 (beta) |
109 | 100507605 | 3.4 | 2.3 | 1.8 | 0.0 | -1.021 | 0.4145 | LINC00837 | long intergenic non-protein coding RNA 837 |
110 | 27136 | 3.5 | 2.5 | 2.0 | 0.2 | -0.852 | 0.4827 | MORC1 | MORC family CW-type zinc finger 1 |
111 | 3587 | 5.3 | 2.6 | 1.0 | 0.2 | -4.687 | 0.0340 | IL10RA | interleukin 10 receptor, alpha |
112 | 1133 | 2.8 | 3.1 | 0.4 | 0.3 | 0.975 | 0.3954 | CHRM5 | cholinergic receptor, muscarinic 5 |
113 | 5624 | 4.3 | 2.7 | 0.1 | 0.5 | -5.838 | 0.0246 | PROC | protein C (inactivator of coagulation factors Va and VIIIa) |
114 | 43 | 6.1 | 6.4 | 0.4 | 0.3 | 1.045 | 0.3591 | ACHE | acetylcholinesterase (Yt blood group) |
115 | 9651 | 5.1 | 5.1 | 0.1 | 0.2 | -0.103 | 0.9236 | PLCH2 | phospholipase C, eta 2 |
116 | 778 | 3.1 | 2.3 | 1.4 | 0.0 | -1.005 | 0.4205 | CACNA1F | calcium channel, voltage-dependent, L type, alpha 1F subunit |
117 | 2049 | 7.6 | 9.2 | 0.4 | 0.3 | 5.606 | 0.0083 | EPHB3 | EPH receptor B3 |
118 | 2078 | 2.3 | 2.7 | 0.1 | 0.3 | 2.051 | 0.1704 | ERG | v-ets avian erythroblastosis virus E26 oncogene homolog |
119 | 4004 | 9.5 | 8.5 | 0.6 | 0.2 | -2.775 | 0.0886 | LMO1 | LIM domain only 1 (rhombotin 1) |
120 | 8392 | 3.4 | 4.4 | 1.0 | 0.2 | 1.534 | 0.2579 | OR3A3 | olfactory receptor, family 3, subfamily A, member 3 |
121 | 4214 | 11.6 | 11.1 | 0.1 | 0.1 | -4.921 | 0.0154 | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
122 | 8842 | 3.8 | 2.6 | 0.7 | 0.2 | -2.953 | 0.0863 | PROM1 | prominin 1 |
123 | 79725 | 7.4 | 7.2 | 0.9 | 0.2 | -0.431 | 0.7041 | THAP9 | THAP domain containing 9 |
124 | 10457 | 4.0 | 3.9 | 0.3 | 0.5 | -0.142 | 0.8949 | GPNMB | glycoprotein (transmembrane) nmb |
125 | 7018 | 4.1 | 3.5 | 1.4 | 0.3 | -0.712 | 0.5459 | TF | transferrin |
126 | 11250 | 3.2 | 3.2 | 0.9 | 0.7 | 0.018 | 0.9865 | GPR45 | G protein-coupled receptor 45 |
127 | 6981 | 5.4 | 3.4 | 0.4 | 0.9 | -3.549 | 0.0443 | TRGV7 | T cell receptor gamma variable 7 (pseudogene) |
128 | 140 | 2.5 | 2.2 | 0.5 | 0.0 | -1.027 | 0.4122 | ADORA3 | adenosine A3 receptor |
129 | 4161 | 2.6 | 2.6 | 0.4 | 0.4 | -0.201 | 0.8503 | MC5R | melanocortin 5 receptor |
130 | 5896 | 2.3 | 2.2 | 0.1 | 0.0 | -0.926 | 0.4481 | RAG1 | recombination activating gene 1 |
131 | 11341 | 2.4 | 2.4 | 0.0 | 0.1 | 0.504 | 0.6491 | SCRG1 | stimulator of chondrogenesis 1 |
132 | 5064 | 12.4 | 12.1 | 0.2 | 0.4 | -1.310 | 0.2769 | PALM | paralemmin |
133 | 29986 | 2.4 | 2.5 | 0.0 | 0.1 | 1.683 | 0.2286 | SLC39A2 | solute carrier family 39 (zinc transporter), member 2 |
134 | 1010 | 2.7 | 4.8 | 0.6 | 0.3 | 5.484 | 0.0128 | CDH12 | cadherin 12, type 2 (N-cadherin 2) |
135 | 2668 | 4.5 | 2.5 | 0.5 | 0.2 | -6.028 | 0.0104 | GDNF | glial cell derived neurotrophic factor |
136 | 7356 | 6.7 | 6.7 | 0.2 | 0.1 | -0.120 | 0.9119 | SCGB1A1 | secretoglobin, family 1A, member 1 (uteroglobin) |
137 | 5540 | 4.6 | 4.8 | 0.1 | 0.2 | 1.300 | 0.2658 | NPY4R | neuropeptide Y receptor Y4 |
138 | 6712 | 8.9 | 8.7 | 0.2 | 0.0 | -1.988 | 0.1666 | SPTBN2 | spectrin, beta, non-erythrocytic 2 |
139 | 79969 | 8.6 | 8.4 | 0.1 | 0.3 | -1.394 | 0.2692 | ATAT1 | alpha tubulin acetyltransferase 1 |